Article Details

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance ... - BioSpace

Retrieved on: 2024-01-05 20:43:43

Tags for this article:

Click the tags to see associated articles and topics

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/vico-therapeutics-announces-60-million-54-million-series-b-financing-to-advance-vo659-clinical-stage-program-for-rare-neurological-diseases-and-expand-pipeline/

Excerpt

... Polaris Partners, Pureos Bioventures and Eurazeo. Micah Mackison, CEO of Vico Therapeutics. "This financing positions us to accelerate our efforts ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up